Dr. Michael Hassman, DO
Claim this profileHassman Research Institute
Studies Diabetes
Studies Type 2 Diabetes
14 reported clinical trials
17 drugs studied
Affiliated Hospitals
Clinical Trials Michael Hassman, DO is currently running
Tirzepatide + Mibavademab
for Obesity
The main purpose of this study is to determine if combining tirzepatide with mibavademab will result in more weight loss in adult participants than tirzepatide alone. The study will last about 74 weeks and may include up to 19 visits.
Recruiting0 awards Phase 2
Long-Acting Cabotegravir + rHuPH20
for HIV Infection
This trial is testing a long-lasting HIV medication called Cabotegravir, given as an injection. It also tests if adding rHuPH20 helps the medication spread better in the body. The study focuses on people who need long-term HIV treatment. Cabotegravir is the first long-acting injectable treatment option approved for adults with HIV-1.
Recruiting1 award Phase 17 criteria
More about Michael Hassman, DO
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Michael Hassman, DO has experience with
- Placebo
- Cabotegravir
- Deucravacitinib (BMS-986165)
- Recombinant Human Hyaluronidase PH20 (rHuPH20)
- LY3457263
- Dulaglutide
Breakdown of trials Michael Hassman, DO has run
Diabetes
Type 2 Diabetes
Human Immunodeficiency Virus Infection
Obesity
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Hassman, DO specialize in?
Michael Hassman, DO focuses on Diabetes and Type 2 Diabetes. In particular, much of their work with Diabetes has involved treating patients, or patients who are undergoing treatment.
Is Michael Hassman, DO currently recruiting for clinical trials?
Yes, Michael Hassman, DO is currently recruiting for 5 clinical trials in Berlin New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Michael Hassman, DO has studied deeply?
Yes, Michael Hassman, DO has studied treatments such as Placebo, Cabotegravir, Deucravacitinib (BMS-986165).
What is the best way to schedule an appointment with Michael Hassman, DO?
Apply for one of the trials that Michael Hassman, DO is conducting.
What is the office address of Michael Hassman, DO?
The office of Michael Hassman, DO is located at: Hassman Research Institute, Berlin, New Jersey 08009 United States. This is the address for their practice at the Hassman Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.